Medpace (MEDP) Competitors $337.35 +0.53 (+0.16%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MEDP vs. TCOM, IQV, RDDT, GIB, CPAY, AER, KSPI, GRAB, ICLR, and GFLShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Trip.com Group (TCOM), IQVIA (IQV), Reddit (RDDT), CGI (GIB), Corpay (CPAY), AerCap (AER), Joint Stock Company Kaspi.kz (KSPI), Grab (GRAB), ICON Public (ICLR), and GFL Environmental (GFL). These companies are all part of the "business services" industry. Medpace vs. Trip.com Group IQVIA Reddit CGI Corpay AerCap Joint Stock Company Kaspi.kz Grab ICON Public GFL Environmental Medpace (NASDAQ:MEDP) and Trip.com Group (NASDAQ:TCOM) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, community ranking, dividends, valuation and earnings. Which has higher earnings and valuation, MEDP or TCOM? Trip.com Group has higher revenue and earnings than Medpace. Trip.com Group is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$1.89B5.56$282.81M$11.4229.54Trip.com Group$6.27B6.90$1.40B$3.3420.11 Is MEDP or TCOM more profitable? Trip.com Group has a net margin of 31.86% compared to Medpace's net margin of 17.66%. Medpace's return on equity of 50.87% beat Trip.com Group's return on equity.Company Net Margins Return on Equity Return on Assets Medpace17.66% 50.87% 19.61% Trip.com Group 31.86%12.04%6.70% Which has more volatility and risk, MEDP or TCOM? Medpace has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Trip.com Group has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Do institutionals & insiders have more ownership in MEDP or TCOM? 78.0% of Medpace shares are held by institutional investors. Comparatively, 35.4% of Trip.com Group shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 23.0% of Trip.com Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts recommend MEDP or TCOM? Medpace presently has a consensus price target of $380.56, suggesting a potential upside of 12.81%. Trip.com Group has a consensus price target of $74.78, suggesting a potential upside of 11.35%. Given Medpace's higher possible upside, equities analysts plainly believe Medpace is more favorable than Trip.com Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45Trip.com Group 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Does the MarketBeat Community favor MEDP or TCOM? Medpace received 253 more outperform votes than Trip.com Group when rated by MarketBeat users. Likewise, 63.65% of users gave Medpace an outperform vote while only 56.90% of users gave Trip.com Group an outperform vote. CompanyUnderperformOutperformMedpaceOutperform Votes35263.65% Underperform Votes20136.35% Trip.com GroupOutperform Votes9956.90% Underperform Votes7543.10% Does the media prefer MEDP or TCOM? In the previous week, Medpace had 3 more articles in the media than Trip.com Group. MarketBeat recorded 8 mentions for Medpace and 5 mentions for Trip.com Group. Medpace's average media sentiment score of 0.80 beat Trip.com Group's score of 0.73 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Trip.com Group 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMedpace beats Trip.com Group on 11 of the 19 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.48B$4.14B$5.21B$9.15BDividend YieldN/A1.82%5.13%4.03%P/E Ratio29.5448.2588.4817.36Price / Sales5.5644.721,243.3177.98Price / Cash34.8323.2643.7535.97Price / Book18.523.335.314.79Net Income$282.81M$139.50M$122.62M$225.00M7 Day Performance-4.16%-0.36%0.61%2.62%1 Month Performance0.02%-3.53%2.55%3.81%1 Year Performance14.09%18.90%25.31%20.10% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.5467 of 5 stars$337.35+0.2%$380.56+12.8%+14.1%$10.48B$1.89B29.545,900TCOMTrip.com Group4.7483 of 5 stars$63.76+1.0%$74.78+17.3%+86.9%$41.07B$48.74B19.0936,249IQVIQVIA4.9228 of 5 stars$204.21+0.5%$255.82+25.3%-8.4%$37.06B$15.32B26.8086,000Short Interest ↑RDDTReddit1.5227 of 5 stars$163.15-2.4%$136.75-16.2%N/A$28.65B$1.12B0.002,013Insider TradeGIBCGI3.7957 of 5 stars$107.90+0.2%$147.25+36.5%-0.1%$24.59B$14.68B20.0691,500Short Interest ↑CPAYCorpay4.0826 of 5 stars$349.73+0.4%$377.50+7.9%N/A$24.38B$3.88B24.9510,500Short Interest ↓AERAerCap3.2119 of 5 stars$94.70+0.6%$112.00+18.3%+26.8%$18.74B$7.82B7.50740KSPIJoint Stock Company Kaspi.kz3.6553 of 5 stars$90.88-0.8%$147.20+62.0%N/A$18.13B$2.36T0.008,772Short Interest ↑GRABGrab2.1183 of 5 stars$4.47-0.4%$5.55+24.1%+50.0%$18.00B$2.69B-223.509,490Short Interest ↑Gap DownICLRICON Public4.3055 of 5 stars$217.43-0.4%$287.00+32.0%-23.7%$17.94B$8.31B24.2441,100Analyst RevisionGFLGFL Environmental2.7228 of 5 stars$44.14-0.1%$45.80+3.8%+24.1%$17.36B$7.76B-33.1920,000 Related Companies and Tools Related Companies Trip.com Group Alternatives IQVIA Alternatives Reddit Alternatives CGI Alternatives Corpay Alternatives AerCap Alternatives Joint Stock Company Kaspi.kz Alternatives Grab Alternatives ICON Public Alternatives GFL Environmental Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MEDP) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts